Found 6 matching trials
Asacol Acute Diverticulitis(DIVA)Study
PHASE2The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg...
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
PHASE3The purpose of this study is to determine whether low dose Asacol® (27 mg/k...
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
PHASE3To demonstrate that import Mesalazine (ASACOL®) is non-inferior to the refe...
Location
Shanghai Hospital
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
PHASE3The overall objective of this study is to assess the safety and efficacy of...
Location
Research Facility
(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
PHASE3The purpose of this study is to compare Budesonide MMX™ 6 mg and Budesonide...
Location
Santarus Clinical Investigational Site 5051
A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
PHASE3The objectives of this bioequivalence study in patients with ulcerative col...
Location
Multiple Locations